In vitro analysis of huntingtin-mediated transcriptional repression reveals multiple transcription factor targets

Cell

Volumn 123, Issue 7, 2005, Pages 1241-1253

  Zhai, Weiguo ^a   Jeong, Hyunkyung ^b   Cui, Libin ^b   Krainc, Dimitri ^b   Tjian, Robert ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HUNTINGTIN;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL PROTECTION; CONTROLLED STUDY; GENE MUTATION; GENE OVEREXPRESSION; GENE REPRESSION; GENE TARGETING; GENETIC ANALYSIS; GENETIC TRANSCRIPTION; MOLECULAR DYNAMICS; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALIA;

EID: 29244462838     PISSN: 00928674     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cell.2005.10.030     Document Type: Article

References (34)

1. S.R. Albright, and R. Tjian TAFs revisited: more data reveal new twists and confirm old ideas Gene 242 2000 1 13
2. J.H. Cha Transcriptional dysregulation in Huntington's disease Trends Neurosci. 23 2000 387 392
3. J.L. Chen, L.D. Attardi, C.P. Verrijzer, K. Yokomori, and R. Tjian Assembly of recombinant TFIID reveals differential coactivator requirements for distinct transcriptional activators Cell 79 1994 93 105
4. J.W. Conaway, A. Shilatifard, A. Dvir, and R.C. Conaway Control of elongation by RNA polymerase II Trends Biochem. Sci. 25 2000 375 380
5. A.J. Courey, and R. Tjian Analysis of Sp1 in vivo reveals multiple transcriptional domains, including a novel glutamine-rich activation motif Cell 55 1988 887 898
6. M. DiFiglia, E. Sapp, K. Chase, C. Schwarz, A. Meloni, C. Young, E. Martin, J.P. Vonsattel, R. Carraway, and S.A. Reeves Huntingtin is a cytoplasmic protein associated with vesicles in human and rat brain neurons Neuron 14 1995 1075 1081
7. M. DiFiglia, E. Sapp, K.O. Chase, S.W. Davies, G.P. Bates, J.P. Vonsattel, and N. Aronin Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain Science 277 1997 1990 1993
8. A.W. Dunah, H. Jeong, A. Griffin, Y.M. Kim, D.G. Standaert, S.M. Hersch, M.M. Mouradian, A.B. Young, N. Tanese, and D. Krainc Sp1 and TAFII130 transcriptional activity disrupted in early Huntington's disease Science 296 2002 2238 2243
9. W. Frejtag, Y. Zhang, R. Dai, M.G. Anderson, and N.F. Mivechi Heat shock factor-4 (HSF-4a) represses basal transcription through interaction with TFIIF J. Biol. Chem. 276 2001 14685 14694
10. F. Gaiser, S. Tan, and T.J. Richmond Novel dimerization fold of RAP30/RAP74 in human TFIIF at 1.7 Å resolution J. Mol. Biol. 302 2000 1119 1127
11. K.P. Garrett, H. Serizawa, J.P. Hanley, J.N. Bradsher, A. Tsuboi, N. Arai, T. Yokota, K. Arai, R.C. Conaway, and J.W. Conaway The carboxyl terminus of RAP30 is similar in sequence to region 4 of bacterial sigma factors and is required for function J. Biol. Chem. 267 1992 23942 23949
12. H.P. Gerber, K. Seipel, O. Georgiev, M. Hofferer, M. Hug, S. Rusconi, and W. Schaffner Transcriptional activation modulated by homopolymeric glutamine and proline stretches Science 263 1994 808 811
13. M. Hoshino, K. Tagawa, T. Okuda, and H. Okazawa General transcriptional repression by polyglutamine disease proteins is not directly linked to the presence of inclusion bodies Biochem. Biophys. Res. Commun. 313 2004 110 116
14. B. Lemon, C. Inouye, D.S. King, and R. Tjian Selectivity of chromatin-remodelling cofactors for ligand-activated transcription Nature 414 2001 924 928
15. S.H. Li, A.L. Cheng, H. Zhou, S. Lam, M. Rao, H. Li, and X.J. Li Interaction of Huntington disease protein with transcriptional activator Sp1 Mol. Cell. Biol. 22 2002 1277 1287
16. R. Luthi-Carter, S.A. Hanson, A.D. Strand, D.A. Bergstrom, W. Chun, N.L. Peters, A.M. Woods, E.Y. Chan, C. Kooperberg, and D. Krainc Dysregulation of gene expression in the R6/2 model of polyglutamine disease: parallel changes in muscle and brain Hum. Mol. Genet. 11 2002 1911 1926
17. R. Luthi-Carter, A.D. Strand, S.A. Hanson, C. Kooperberg, G. Schilling, A.R. La Spada, D.E. Merry, A.B. Young, C.A. Ross, D.R. Borchelt, and J.M. Olson Polyglutamine and transcription: gene expression changes shared by DRPLA and Huntington's disease mouse models reveal context-independent effects Hum. Mol. Genet. 11 2002 1927 1937
18. L. Mangiarini, K. Sathasivam, M. Seller, B. Cozens, A. Harper, C. Hetherington, M. Lawton, Y. Trottier, H. Lehrach, S.W. Davies, and G.P. Bates Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice Cell 87 1996 493 506
19. S. McCracken, and J. Greenblatt Related RNA polymerase-binding regions in human RAP30/74 and Escherichia coli sigma 70 Science 253 1991 900 902
20. L.B. Menalled, J.D. Sison, I. Dragatsis, S. Zeitlin, and M.F. Chesselet Time course of early motor and neuropathological anomalies in a knock-in mouse model of Huntington's disease with 140 CAG repeats J. Comp. Neurol. 465 2003 11 26
21. A.M. Naar, P.A. Beaurang, S. Zhou, S. Abraham, W. Solomon, and R. Tjian Composite co-activator ARC mediates chromatin-directed transcriptional activation Nature 398 1999 828 832
22. H. Okazawa Polyglutamine diseases: a transcription disorder? Cell. Mol. Life Sci. 60 2003 1427 1439
23. M.F. Perutz, J.T. Finch, J. Berriman, and A. Lesk Amyloid fibers are water-filled nanotubes Proc. Natl. Acad. Sci. USA 99 2002 5591 5595
24. M.A. Poirer, H. Li, J. Macosko, S. Cai, M. Amzel, and C.A. Ross Huntingtin spheroids and protofibrils as precursors in polyglutamine fibrilization J. Biol. Chem. 277 2002 41032 41037
25. D.C. Rubinsztein, D.E. Barton, B.C. Davison, and M.A. Ferguson-Smith Analysis of the huntingtin gene reveals a trinucleotide-length polymorphism in the region of the gene that contains two CCG-rich stretches and a correlation between decreased age of onset of Huntington's disease and CAG repeat number Hum. Mol. Genet. 2 1993 1713 1715
26. S. Ryu, S. Zhou, A.G. Ladurner, and R. Tjian The transcriptional cofactor complex CRSP is required for activity of the enhancer-binding protein Sp1 Nature 397 1999 446 450
27. F. Saudou, S. Finkbeiner, D. Devys, and M.E. Greenberg Huntingtin acts in the nucleus to induce apoptosis but death does not correlate with the formation of intranuclear inclusions Cell 95 1998 55 66
28. E. Scherzinger, R. Lurz, M. Turmaine, L. Mangiarini, B. Hollenback, R. Hasenbank, G.P. Bates, S.W. Davies, H. Lehrach, and E.E. Wanker Huntingtin-encoded polyglutamine expansions form amyloid-like protein aggregates in vitro and in vivo Cell 90 1997 549 558
29. S. Sipione, and E. Cattaneo Modeling Huntington's disease in cells, flies, and mice Mol. Neurobiol. 23 2001 21 51
30. J.S. Steffan, L. Bodai, J. Pallos, M. Poelman, A. McCampbell, B.L. Apostol, A. Kazantsev, E. Schmidt, Y.Z. Zhu, and M. Greenwald Histone deacetylase inhibitors arrest polyglutamine-dependent neurodegeneration in Drosophila Nature 413 2001 739 743
31. K.L. Sugars, and D.C. Rubinsztein Transcriptional abnormalities in Huntington disease Trends Genet. 19 2003 233 238
32. S. Tan, R.C. Conaway, and J.W. Conaway Dissection of transcription factor TFIIF functional domains required for initiation and elongation Proc. Natl. Acad. Sci. USA 92 1995 6042 6046
33. N. Tanese, B.F. Pugh, and R. Tjian Coactivators for a proline-rich activator purified from the multisubunit human TFIID complex Genes Dev. 5 1991 2212 2224
34. The Huntington's Disease Collaborative Research Group A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes Cell 72 1993 971 983